MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    Impact of GBA Mutations in the Outcomes of Deep Brain Stimulation in Parkinson’s

    M. Roque, R. Barbosa, P. Pita Lobo, A. Valadas, B. Cattoni, H. Carvalho, M. Rosa, J. Ferreira, M. Coelho, L. Guedes (Lisbon, Portugal)

    Objective: Our study aims to investigate the influence of GBA gene mutations in the outcomes of DBS in PD through the assessment of motor and…
  • 2022 International Congress

    Can treatment of Helicobacter pylori decrease Parkinson’s disease risk?

    L. Eisenberg, N. Giladi, V. Rozani, C. Peretz (Tel Aviv, Israel)

    Objective: The aim of this study was to investigate the association between Helicobacter pylori (H. pylori) infection and the risk of Parkinson’s disease (PD). Background:…
  • 2022 International Congress

    Feasibility and acceptability of PDConnect: a collaborative approach to physical activity for people with Parkinson’s.

    J. Jones, L. Alexander, L. Hancock, K. Cooper (Aberdeen, United Kingdom)

    Objective: To evaluate the feasibility and acceptability of a novel collaborative telehealth based physical activity intervention for people with Parkinson’s. Background: The benefits of physical…
  • 2022 International Congress

    Postural Instability in Parkinson’s Disease: Phenotypic data from The Cincinnati Cohort Biomarker Program

    K. Duque, J. Abanto, R. Bode, N. Gregor, F. Pariona, J. Hernandez, A. Espay, L. Marsili (Cincinnati, USA)

    Objective: To estimate the onset of postural instability in a cohort of Parkinson's disease (PD) patients. Background: The Cincinnati Cohort Biomarker Program (CCBP), launched in…
  • 2022 International Congress

    Amantadine Delayed Release/Extended Release Capsules Reduce the Proportion of the Day Spent in “BAD” Time (ON with Troublesome Dyskinesia or OFF): Analysis of Phase 3 Trial Data

    R. Hauser, R. Pahwa, A. Formella (Tampa, USA)

    Objective: To evaluate the effect of treatment with amantadine delayed release/extended release (AMT DR/ER) vs. placebo on the proportion of the waking day spent in…
  • 2022 International Congress

    Sex Differences for Tau Association with Cognition in Early Parkinson’s Disease

    E. Bayram, A. Tsai, K. Wang, I. Litvan (La Jolla, USA)

    Objective: To assess sex differences for cerebrospinal fluid (CSF) phosphorylated tau (p-tau) association with cognition in Parkinson’s disease (PD) Background: Tau biomarkers can predict cognitive…
  • 2022 International Congress

    The East London Parkinson Disease Project – engaging a diverse population in research

    A. Zirra, A. Ben-Joseph, T. Haque, D. Gallagher, C. Budu, B. Huxford, C. Simonet, A. Noyce (London, United Kingdom)

    Objective: The objective of this study was to engage a diverse group of people with Parkinson disease (PwP) from East London and build a research…
  • 2022 International Congress

    Parkinson’s disease symptom asymmetry at disease onset corresponds to low-beta power asymmetry in the subthalamic nucleus

    A. Buijink, F. Torrecillos, M. Stam, D. Piña-Fuentes, A. Pogosyan, C. Wiest, R. de Bie, P. Schuurman, G. Tinkhauser, H. Tan, M. Beudel (Amsterdam, Netherlands)

    Objective: Compare beta-power in the subthalamic nucleus (STN) between the most affected and least affected body side at disease onset. Background: Exaggerated beta activity (13–35…
  • 2022 International Congress

    A Study of Battery Replacement Characteristics of Patients with Parkinson’s Disease and Factors Influencing Battery Drain

    P. Sharma, P. Pal, D. Srinivas, N. Kamble, R. Yadav, V. Holla (Bangalore, India)

    Objective: To correlate the clinical and stimulation parameters in patients with PD who have undergone DBS and battery replacement Background: Battery life depends on the…
  • 2022 International Congress

    Dysphagia management in Parkinson’s patients during admission to Royal Berkshire Hospital(RBH),Reading,UK.

    M. Khwaja, G. Desai, J. Murphy, A. Chatterjee (Reading, United Kingdom)

    Objective: To evaluate dysphagia management in Parkinson’s patients according to National Confidential Enquiry into Patient Outcome and Death(NCEPOD)report 2021 recommendations. Background: Dysphagia is inevitable in…
  • « Previous Page
  • 1
  • …
  • 329
  • 330
  • 331
  • 332
  • 333
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley